1:17-cv-01078 - Insys Development Company Inc et al. v. Par Pharmaceutical Inc et al.Report Error
Detail
Case Number
1:17-cv-01078Current Status
closedCause of Action
Infringement
Related Case(s)
1:17-cv-01419
Court
Delaware District CourtPlaintiff(s)
Insys Development Company Inc
Insys Therapeutics Inc
Defendant(s)
Par Pharmaceutical Inc
Endo Generics Holdings Inc
Judge
Leonard P. StarkFiling Date
2017-08-03Termination Date
2018-03-27Dockets
| Text |
|---|
| UPDATED CIVIL DOCKET |
| UPDATED CIVIL DOCKET |
| SO ORDERED, re 36 Stipulated Protective Order filed by Par Pharmaceutical, Inc. Signed by Judge Leonard P. Stark on 12/22/17. (ntl) (Entered: 12/22/2017) |
| COMPLAINT FOR PATENT INFRINGEMENT filed against Endo Generics Holdings, Inc., Par Pharmaceutical, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2195816.) - filed by Insys Therapeutics, Inc., Insys Development Company, Inc.. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(jcs) (Entered: 08/03/2017) |
| DECLARATION of Mailing (as to service on Par Pharmaceutical, Inc.) by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Attachments: # 1 Exhibit A & B)(Noreika, Maryellen) (Entered: 08/08/2017) |
| STIPULATION TO EXTEND TIME to ANSWER Complaint to September 1, 2017 - filed by Endo Generics Holdings, Inc., Par Pharmaceutical, Inc.. (Attachments: # 1 Certificate of Service)(Pascale, Karen) (Entered: 08/25/2017) |
| [SEALED] ANSWER to 1 Complaint, Defenses and, COUNTERCLAIM against All Plaintiffs by Par Pharmaceutical, Inc.. (Attachments: # 1 Exhibits A to E of the Complaint)(Pascale, Karen) (Entered: 09/06/2017) |
| REDACTED VERSION of 14 Answer to Complaint, Counterclaim by Par Pharmaceutical, Inc.. (Attachments: # 1 [Public Version ]Exhibits to Answer, # 2 Certificate of Service)(Pascale, Karen) (Entered: 09/13/2017) |
| MOTION for Pro Hac Vice Appearance of Attorney David H. Silverstein, Aziz Burgy, Christopher M. Gallo and Ricardo S. Camposanto of Axinn, Veltrop & Harkrider LLP - filed by Par Pharmaceutical, Inc.. (Attachments: # 1 Certifications of Counsel, # 2 Certificate of Service)(Pascale, Karen) (Entered: 09/18/2017) |
| Joint PROPOSED ORDER - [Proposed] Scheduling Order - by Par Pharmaceutical, Inc.. (Attachments: # 1 Chart of Proposed Dates for Scheduling Order)(Pascale, Karen) (Entered: 11/03/2017) |
| PROPOSED ORDER Revised Proposed Scheduling Order by Par Pharmaceutical, Inc.. (Attachments: # 1 Transmittal Letter to Judge Stark from Karen L. Pascale)(Pascale, Karen) (Entered: 12/01/2017) |
| [SEALED] MOTION to Redact 32 Transcript,, - filed by Par Pharmaceutical, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Text of Proposed Order, # 4 Certificate of Service)(Pascale, Karen) (Entered: 12/28/2017) |
| Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) (Entered: 08/03/2017) |
| Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/23/2017. Date of Expiration of Patent: August 6, 2028.Thirty Month Stay Deadline: 12/23/2019. (jcs) (Entered: 08/03/2017) |
| Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,222,292 B2; 9,345,771 B2. (jcs) (Entered: 08/03/2017) |
| Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Insys Therapeutics, Inc. for Insys Therapeutics, Inc. Insys Therapeutics, Inc. is a publicly held company that does not have a parent corporation. filed by Insys Development Company, Inc., Insys Therapeutics, Inc.(jcs) (Entered: 08/03/2017) |
| SUMMONS Returned Executed by Insys Therapeutics, Inc., Insys Development Company, Inc.. Endo Generics Holdings, Inc. served on 8/4/2017, answer due 8/25/2017. (Noreika, Maryellen) (Entered: 08/04/2017) |
| MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr., Chad J. Peterman, Naveen Modi, Michael A. Stramiello, and Lucas L. Kressel - filed by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Noreika, Maryellen) (Entered: 08/17/2017) |
| STIPULATION Dismissing Endo Generics Holdings, Inc. by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Noreika, Maryellen) (Entered: 08/31/2017) |
| STIPULATION and Order for Leave to File Defendants Answer, Defenses and Counterclaims Under Seal by Endo Generics Holdings, Inc., Par Pharmaceutical, Inc.. (Pascale, Karen) (Entered: 09/01/2017) |
| NOTICE OF SERVICE of [SEALED] Defendant Par Pharmaceutical, Inc.s Answer, Defenses and Counterclaims to Plaintiffs Complaint filed by Par Pharmaceutical, Inc..(Pascale, Karen) (Entered: 09/01/2017) |
| Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Endo International PLC for Par Pharmaceutical, Inc. filed by Par Pharmaceutical, Inc.. (Pascale, Karen) (Entered: 09/01/2017) |
| [SEALED] ANSWER to 14 Answer to Complaint, Counterclaim by Insys Development Company, Inc., Insys Therapeutics, Inc..(Noreika, Maryellen) (Entered: 09/22/2017) |
| REDACTED VERSION of 17 Answer to Counterclaim by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Noreika, Maryellen) (Entered: 09/29/2017) |
| Letter to The Honorable Leonard P. Stark from Karen L. Pascale regarding Defendants request for scheduling conference or deadline to submit joint proposed scheduling order. (Pascale, Karen) (Entered: 10/19/2017) |
| Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding Oral Order - re 20 Order,. (Blumenfeld, Jack) (Entered: 10/20/2017) |
| Letter to The Honorable Leonard P. Stark from Karen L.Pascale regarding Plaintiffs letter requesting coordinated scheduling - re 21 Letter. (Pascale, Karen) (Entered: 10/20/2017) |
| Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding follow up to October 20, 2017 letter - re 21 Letter. (Noreika, Maryellen) (Entered: 10/24/2017) |
| Letter to The Honorable Leonard P. Stark from Karen L. Pascale regarding response to Plaintiffs letter (DI 23) requesting postponement of scheduling order - re 23 Letter. (Pascale, Karen) (Entered: 10/25/2017) |
| NOTICE OF SERVICE of Defendant Par Pharmaceutical, Inc.s First Set of Interrogatories to Plaintiffs (Nos. 1-5) and Defendant Par Pharmaceutical, Inc.s First Set of Requests for Admission to Plaintiffs (Nos. 1-9) filed by Par Pharmaceutical, Inc..(Pascale, Karen) (Entered: 11/07/2017) |
| Letter to The Honorable Leonard P. Stark from Karen L. Pascale regarding Defendants request for a Rule 16 Scheduling Conference - re 26 Proposed Order. (Pascale, Karen) (Entered: 11/15/2017) |
| SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Discovery due by 7/20/2018. A Status Conference is set for 8/10/2018 at 02:30 PM in Courtroom 6B before Judge Leonard P. Stark. Status Report due by 8/7/2018. Claim Construction Opening Brief due by 4/26/2018. Claim Construction Answering Brief due by 5/24/2018. A Markman Hearing is set for 6/4/2018 at 01:00 PM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 11/30/2018. A Final Pretrial Conference is set for 12/7/2018 at 11:30 AM in Courtroom 6B before Judge Leonard P. Stark. A 5-day Bench Trial is set for 12/17/2018 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 12/6/17. (ntl) (Entered: 12/06/2017) |
| [SEALED] Official Transcript of Telephone Conference held on November 28, 2017 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. (bpg) Modified on 1/9/2018 (ntl). (Entered: 12/07/2017) |
| NOTICE OF SERVICE of (1) Plaintiffs Objections and Responses to Defendants First Set of Interrogatories to Plaintiffs (Nos. 1-5) and (2) Plaintiffs Objections and Responses to Defendants First Set of Requests for Admission to Plaintiffs (Nos. 1-9) filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Blumenfeld, Jack) (Entered: 12/07/2017) |
| NOTICE of Intent to Request Redaction by Karen L. Pascale re 32 Transcript,, (Pascale, Karen) (Entered: 12/14/2017) |
| PROPOSED ORDER Stipulated Protective Order by Par Pharmaceutical, Inc.. (Pascale, Karen) (Entered: 12/14/2017) |
| PROPOSED ORDER Stipulated Protective Order (REVISED) by Par Pharmaceutical, Inc.. (Pascale, Karen) (Entered: 12/19/2017) |
| NOTICE OF SERVICE of Plaintiffs Rule 26(a)(1) Initial Disclosures filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Noreika, Maryellen) (Entered: 12/20/2017) |
| NOTICE OF SERVICE of Par Pharmaceutical Inc.s Rule 26(a)(1) Disclosures filed by Par Pharmaceutical, Inc..(Pascale, Karen) (Entered: 12/20/2017) |
| NOTICE OF SERVICE of Defendant Par Pharmaceutical, Incs Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery - [CONFIDENTIAL - SUBJECT TO PROTECTIVE ORDER] filed by Par Pharmaceutical, Inc..(Pascale, Karen) (Entered: 12/28/2017) |
| NOTICE OF SERVICE of Plaintiffs Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Blumenfeld, Jack) (Entered: 01/03/2018) |
| ORDER re 39 MOTION to Redact 32 Transcript filed by Par Pharmaceutical, Inc. Signed by Judge Leonard P. Stark on 1/9/18. (ntl) (Entered: 01/09/2018) |
| Redaction of 32 . Official Transcript of Telephone Conference held on November 28, 2017 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. (bpg) (Entered: 01/17/2018) |
| ORDER Setting Mediation Conference: A Telephone Conference is set for 2/26/2018 at 10:00 AM before Judge Christopher J. Burke. to discuss ADR.Signed by Judge Christopher J. Burke on 1/24/2018. (dlb) (Entered: 01/24/2018) |
| STIPULATION TO EXTEND TIME for the plaintiffs to provide defendant with their infringement contentions and for the parties to exchange a list of claim terms/phrases needing constructions and the proposed constructions to March 6, 2018 and March 8, 2018, respectively - filed by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Noreika, Maryellen) (Entered: 03/01/2018) |
| NOTICE OF SERVICE of Plaintiffs Infringement Contentions Against Par for Infringement of the 292 and 771 Patents filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Noreika, Maryellen) (Entered: 03/08/2018) |
| NOTICE OF SERVICE of Defendant Par Pharmaceutical, Inc.s Claim Terms for Construction and Proposed Constructions filed by Par Pharmaceutical, Inc..(Pascale, Karen) (Entered: 03/08/2018) |
| NOTICE OF SERVICE of Plaintiffs Proposed Terms for Claim Construction filed by Insys Development Company, Inc., Insys Therapeutics, Inc..(Noreika, Maryellen) (Entered: 03/08/2018) |
| STIPULATION TO EXTEND TIME for the parties to submit joint claim charts to March 22, 2018 - filed by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Noreika, Maryellen) (Entered: 03/15/2018) |
| STIPULATION of Dismissal (without prejudice) by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Noreika, Maryellen) (Entered: 03/22/2018) |
Timeline
filed_date
closed_date
Aug
Sep
Oct
Nov
Dec
2018
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2019
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2020
Feb
Mar
Apr
May
Jun
Jul
Patents In Case